Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.895 USD | -3.02% | -5.75% | -34.91% |
Mar. 27 | Wells Fargo Trims Price Target on Bluebird Bio to $3 From $4, Maintains Equalweight Rating | MT |
Mar. 27 | Wedbush Adjusts bluebird bio's PT to $1.72 From $1.68, Maintains Neutral Rating | MT |
Financials (USD)
Sales 2023 * | 37.41M | Sales 2024 * | 125M | Capitalization | 178M |
---|---|---|---|---|---|
Net income 2023 * | -199M | Net income 2024 * | -236M | EV / Sales 2023 * | -1.68 x |
Net cash position 2023 * | 241M | Net cash position 2024 * | 106M | EV / Sales 2024 * | 0.57 x |
P/E ratio 2023 * |
-0.55
x | P/E ratio 2024 * |
-0.58
x | Employees | 323 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 99.62% |
Latest transcript on bluebird bio, Inc.
1 day | -2.48% | ||
1 week | -6.31% | ||
Current month | -30.24% | ||
1 month | -34.35% | ||
3 months | -20.28% | ||
6 months | -69.32% | ||
Current year | -35.30% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Obenshain
CEO | Chief Executive Officer | 51 | 15-12-31 |
Director of Finance/CFO | 51 | 22-11-06 | |
Melissa Bonner
CTO | Chief Tech/Sci/R&D Officer | - | 21-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Vachon
CHM | Chairman | 65 | 14-07-15 |
Nick Leschly
BRD | Director/Board Member | 51 | 10-02-28 |
Richard Paulson
BRD | Director/Board Member | 56 | 23-04-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.47% | 16 M€ | -7.62% | ||
0.11% | 237 M€ | +1.16% | - | |
0.10% | 12 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.8957 | -2.95% | 3 869 884 |
24-04-24 | 0.9229 | -4.91% | 8,181,045 |
24-04-23 | 0.9706 | +1.78% | 4,789,119 |
24-04-22 | 0.9536 | -6.51% | 4,581,972 |
24-04-19 | 1.02 | +7.03% | 8,178,424 |
Delayed Quote Nasdaq, April 25, 2024 at 12:51 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.30% | 178M | |
-1.95% | 104B | |
+1.93% | 97.42B | |
+0.79% | 22.2B | |
-17.81% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-16.08% | 15.06B | |
+4.19% | 13.98B | |
+34.83% | 11.66B |
- Stock Market
- Equities
- BLUE Stock